TYBOURNE CAPITAL MANAGEMENT (HK) LTD - ZENTALIS PHARMACEUTICALS INC ownership

ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 117 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
TYBOURNE CAPITAL MANAGEMENT (HK) LTD ownership history of ZENTALIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$19,287,410
-28.9%
961,4860.0%2.70%
-8.1%
Q2 2023$27,123,520
-3.4%
961,486
-41.1%
2.93%
+3.7%
Q1 2023$28,075,371
-37.5%
1,632,289
-26.8%
2.83%
-36.9%
Q4 2022$44,940,940
-9.9%
2,231,427
-3.1%
4.48%
-6.6%
Q3 2022$49,857,000
-26.9%
2,301,771
-5.1%
4.79%
-2.7%
Q2 2022$68,173,000
-39.1%
2,426,0950.0%4.92%
-25.7%
Q1 2022$111,940,000
-49.3%
2,426,095
-7.7%
6.63%
+1.1%
Q4 2021$220,944,000
+24.4%
2,628,409
-1.4%
6.56%
+46.6%
Q3 2021$177,556,000
+25.3%
2,664,4090.0%4.47%
+49.9%
Q2 2021$141,747,000
+22.6%
2,664,4090.0%2.98%
+17.6%
Q1 2021$115,609,000
-16.5%
2,664,4090.0%2.54%
-11.9%
Q4 2020$138,389,000
+58.9%
2,664,4090.0%2.88%
+34.3%
Q3 2020$87,100,000
-31.9%
2,664,4090.0%2.14%
-44.9%
Q2 2020$127,945,0002,664,4093.89%
Other shareholders
ZENTALIS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Paradigm Biocapital Advisors LP 300,434$25,254,0007.21%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 2,628,409$220,944,0006.56%
Avidity Partners Management LP 2,715,000$228,223,0004.84%
Matrix Capital Management Company, LP 4,349,279$365,600,0004.07%
Affinity Asset Advisors, LLC 117,500$9,877,0003.59%
Integral Health Asset Management, LLC 120,000$10,087,0002.79%
Ghost Tree Capital, LLC 80,000$6,725,0002.41%
Ikarian Capital, LLC 191,140$16,067,0002.39%
Tri Locum Partners LP 23,632$1,987,0000.78%
Eventide Asset Management 529,000$44,468,0000.57%
View complete list of ZENTALIS PHARMACEUTICALS INC shareholders